PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
30210625-11	2018	In colon cancer PDCs with NCOA4-RET fusion, vandetanib potently inhibited AKT and ERK phosphorylation.	vandetanib	44-54	AKT serine/threonine kinase 1	Homo sapiens	74-77